全文获取类型
收费全文 | 4374篇 |
免费 | 279篇 |
国内免费 | 354篇 |
出版年
2024年 | 14篇 |
2023年 | 95篇 |
2022年 | 117篇 |
2021年 | 148篇 |
2020年 | 159篇 |
2019年 | 205篇 |
2018年 | 165篇 |
2017年 | 192篇 |
2016年 | 157篇 |
2015年 | 163篇 |
2014年 | 254篇 |
2013年 | 363篇 |
2012年 | 155篇 |
2011年 | 252篇 |
2010年 | 188篇 |
2009年 | 247篇 |
2008年 | 243篇 |
2007年 | 265篇 |
2006年 | 224篇 |
2005年 | 206篇 |
2004年 | 184篇 |
2003年 | 158篇 |
2002年 | 131篇 |
2001年 | 58篇 |
2000年 | 73篇 |
1999年 | 58篇 |
1998年 | 48篇 |
1997年 | 69篇 |
1996年 | 49篇 |
1995年 | 39篇 |
1994年 | 28篇 |
1993年 | 34篇 |
1992年 | 34篇 |
1991年 | 27篇 |
1990年 | 25篇 |
1989年 | 13篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 21篇 |
1983年 | 29篇 |
1982年 | 17篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1976年 | 3篇 |
1974年 | 3篇 |
排序方式: 共有5007条查询结果,搜索用时 15 毫秒
1.
This paper is concerned with gene survival in a population which may increase without density dependence according to a generalization of the Moran model for haploid individuals. A selective advantage to one allele and the possibility of differential reproductive rates are allowed. Simple conditions are given for ultimate homozygosity to be certain and for the possibility of ultimate polymorphism. The results complement and extend those of Heyde (1981, 1982). 相似文献
2.
3.
《Bioorganic & medicinal chemistry》2016,24(18):4444-4451
Nowadays, AT1 receptor (AT1R) antagonists (ARBs) constitute the one of the most prevalent classes of antihypertensive drugs that modulate the renin-angiotensin system (RAS). Their main uses include also treatment of diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. Towards this direction, our study has been focused on the discovery of novel agents bearing different scaffolds which may evolve as a new class of AT1 receptor antagonists. To fulfill this aim, a combination of computational approaches and biological assays were implemented. Particularly, a pharmacophore model was established and served as a 3D search query to screen the ChEMBL15 database. The reliability and accuracy of virtual screening results were improved by using molecular docking studies. In total, 4 compounds with completely diverse chemical scaffolds from potential ARBs, were picked and tested for their binding affinity to AT1 receptor. Results revealed high nanomolar to micromolar affinity (IC50) for all the compounds. Especially, compound 4 exhibited a binding affinity of 199 nM. Molecular dynamics simulations were utilized in an effort to provide a molecular basis of their binding to AT1R in accordance to their biological activities. 相似文献
4.
In order to investigate gene expression changes associated with cytotoxicity, we used cDNA arrays to monitor the expression
of over 5,000 genes in response to toxic stress in the HepG2 liver cell line. Cells were treated with cytotoxic doses of acetaminophen,
caffeine or thioacetamide for nine time points ranging from 1 to 24 h. Samples of mRNA from each time point were used to prepare
radiolabeled cDNA, which was hybridized to nylon-membrane-based cDNA arrays. High-stringency washes were applied to reduce
cross-hybridization. Analysis of spot intensities revealed that each compound led to approximately 150-250 gene expression
changes that were sustained over at least three adjacent time points. The affected genes could be classified into clusters
based on their temporal patterns of differential expression. A common set of 44 genes showed similar expression changes in
response to all three compounds. Of these changes, 90% could be confirmed by quantitative RT-PCR analysis. The results indicate
that detailed array-based time-course studies, coupled with a sensitive and highly specific confirmation assay, provide a
powerful means of identifying cytotoxicity-associated gene expression changes.
Electronic Publication 相似文献
5.
In searching for differentially expressed genes in human uterine leiomyomas (ULs), suppression sub-tractive hybridization was used to construct an UL up-regulated library, which turned out to represent 88genes. After two rounds of screening by reverse Northern analysis, twenty genes were proved to be up-regulated, including seventeen known genes and three genes with unknown function. All these genes werefirstly associated with UL. Three genes with notable difference were selected for Northern confirmationOur results proved the authenticity of the twenty genes. One gene named Phospholipase A2 (PLA2) showedup-regulation in 4/6 of the patients and investigation of tissue distribution indicated that it had obviousexpression in prostate, testis, liver, heart and skeletal muscle. 相似文献
6.
Fátima H. Vaz Patrícia M. Machado Rita D. Brand?o Cátia T. Laranjeira Joana S. Eugénio Aires H. Fernandes Saudade P. André 《The journal of histochemistry and cytochemistry》2007,55(11):1105-1113
Only 20-25% of families screened for BRCA1/2 mutations are found positive. Because only a positive result is informative, we studied the role of BRCA1/2 immunohistochemistry as an additional method for patient selection. From 53 high-risk-affected probands, 18 (34%) had available paraffin blocks of their tumors and were selected for this study. Mutation screening was done by conformation-sensitive gel electrophoresis and multiplex ligation-dependent probe amplification. For immunohistochemistry, 21 neoplastic specimens (15 breast carcinomas, 5 ovary neoplasms, and 1 rectal adenocarcinoma) were analyzed with BRCA1 (monoclonal antibody, Ab-1, oncogene) and BRCA2 (polyclonal antibody, Ab-2, oncogene) antibodies. Absence of the BRCA1 protein was confirmed in negative tumors by Western blotting. Seven patients were positive for BRCA1/2 mutations: 5 for BRCA1 and 2 for BRCA2. Four out of five positive patients had tumors negative for BRCA1 immunostaining, and the remaining 13 BRCA1-negative patients had positive BRCA1 immunostaining in all tumor samples. Sensitivity to predict for BRCA1 mutation carriers was 80%, and specificity was 100%, with a positive predictive value of 100% and a negative predictive value of 93%. This correlation was statistically significant (p=0.001). No correlation was observed for BRCA2. If larger studies confirm these results, high-risk patients with BRCA1-negative tumors should be screened first for this gene. 相似文献
7.
Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its treatment and prevention represent the paradigmatic example of the ethical dilemmas of 21st-century medicine. New therapies (nusinersen and AVXS-101) hold the promise of being able to treat, but not cure, the condition. Alternatively, genomic analysis could identify carriers, and carriers could be offered in vitro fertilization and preimplantation genetic diagnosis. In the future, gene editing could prevent the condition at the embryonic stage. How should these different options be evaluated and compared within a health system? In this paper, we discuss the ethical considerations that bear on the question of how to prioritize the different treatments and preventive options for SMA, at a policy level. We argue that despite the tremendous value of what we call ‘ex-post’ approaches to treating SMA (such as using pharmacological agents or gene therapy), there is a moral imperative to pursue ‘ex-ante’ interventions (such as carrier screening in combination with prenatal testing and preimplantation genetic diagnosis, or gene editing) to reduce the incidence of SMA. There are moral reasons relating to autonomy, beneficence and justice to prioritize ex-ante methods over ex-post methods. 相似文献
8.
9.
《Bioorganic & medicinal chemistry letters》2014,24(16):3683-3689
Bacterial resistance is inevitable and is a growing concern. It can be addressed only by discovery and development of new agents. However the discovery and development of new antibacterial agents are at an all time low. This article broadly examines the historical as well as current status of antibacterial discovery and provides some perspective as how to address some of the challenges. 相似文献
10.
R. Scheiden C. Wagener U. Knolle A. Wehenkel W. Dippel C. Capesius 《Cytopathology》2003,14(5):235-240
For quality assurance purposes, the results of the 1990's obtained by the National Cervical Cancer Screening Programme (NCCSP) launched in 1962 were reviewed. The positive cytodiagnosis, the histologically verified in situ and invasive cervical cancers and the mortality rates were reported. 相似文献